Literature DB >> 10892711

Sézary syndrome: diagnostic criteria and therapeutic options.

R Russell-Jones1, S Whittaker.   

Abstract

Sézary syndrome (SS) is a rare form of erythrodermic cutaneous T-cell lymphoma with hematological involvement and a poor prognosis. Therapies include photopheresis, with or without interferon, chemotherapy, and total skin electron beam therapy. The lack of any randomized studies makes it difficult to assess the effect of current therapy on survival. In addition, the different response rates reported for individual treatments may depend as much on the criteria used to define SS as the therapy itself. This article reviews the diagnostic tests that are needed to reliably diagnose SS and offers a critical analysis of current treatment options.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10892711     DOI: 10.1016/s1085-5629(00)80006-1

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  1 in total

1.  Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.

Authors:  Machteld M Tiemessen; Tracey J Mitchell; Lisa Hendry; Sean J Whittaker; Leonie S Taams; Susan John
Journal:  J Invest Dermatol       Date:  2006-06-01       Impact factor: 8.551

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.